Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Kahn

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
Psychopharmacology|July 27, 2002
New study designs for new antipsychoticsR S Kahn
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2000
[Atypical antipsychotic drugs]R S Kahn
Psychological Medicine|October 27, 2017
Why the concept of schizophrenia is still alive and kickingR S Kahn
Acta Neuropsychiatrica|March 15, 2016
New dopaminergic and non-dopaminergic theories in schizophrenia and their therapeutic impactR S Kahn
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 5, 1990
Permanent disability in black mineworkersR S Kahn
Nederlands Tijdschrift Voor Geneeskunde|July 17, 1993
[Effect of clozapine in schizophrenia; starting points for current pharmacotherapeutics]R S Kahn
Psychopharmacology|January 1, 1993
Serotonin, dopamine and their interactions in schizophreniaR S Kahn, M Davidson
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2001
Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trialsA Aleman, R S Kahn
Acta Psychiatrica Scandinavica|March 7, 2019
Family interventions and prevention of suicide in first-episode schizophreniaL Sher, R S Kahn
Biological Psychiatry|December 1, 1991
m-Chlorophenylpiperazine as a probe of serotonin functionR S Kahn, S Wetzler
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
Psychopharmacology|July 27, 2002
New study designs for new antipsychoticsR S Kahn
Nederlands Tijdschrift Voor Geneeskunde|September 6, 2000
[Atypical antipsychotic drugs]R S Kahn
Psychological Medicine|October 27, 2017
Why the concept of schizophrenia is still alive and kickingR S Kahn
Acta Neuropsychiatrica|March 15, 2016
New dopaminergic and non-dopaminergic theories in schizophrenia and their therapeutic impactR S Kahn
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 5, 1990
Permanent disability in black mineworkersR S Kahn
Nederlands Tijdschrift Voor Geneeskunde|July 17, 1993
[Effect of clozapine in schizophrenia; starting points for current pharmacotherapeutics]R S Kahn
Psychopharmacology|January 1, 1993
Serotonin, dopamine and their interactions in schizophreniaR S Kahn, M Davidson
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2001
Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trialsA Aleman, R S Kahn
Acta Psychiatrica Scandinavica|March 7, 2019
Family interventions and prevention of suicide in first-episode schizophreniaL Sher, R S Kahn
Biological Psychiatry|December 1, 1991
m-Chlorophenylpiperazine as a probe of serotonin functionR S Kahn, S Wetzler
Pageof 27